Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Carbonate Ion | HCID 19660 | — |
| Reactant | Triacetoxyborohydride | HCID 2724942 | — |
| Reactant | Sarcosine t-butyl ester hydrochloride | HCID 11252350 | — |
| Reactant | HCID 59446872 | HCID 59446872 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 67529240 | HCID 67529240 | — |
Reaction Steps
A solution of 6-((cyclopropylmethyl)(propyl)amino)-N-(4-formyl-2-methylphenyl)pyrimidine-4-carboxamide (Intermediate 29, 100 mg; 0.28 mmol) in DCM (5 ml) was treated with tert-butyl 2-(methylamino)acetate hydrochloride (227.1 mg; 1.24 mmol) and polymer supported carbonate (150 mg) followed by polymer supported triacetoxy borohydride (150 mg). After stirring for 18 hours the mixture was filtered and the solvent removed in vacuo. The residue was purified by column chromatography (silica) eluting with petroleum ether containing increasing amounts of EtOAc to give tert-butyl 2-((4-(6-((cyclopropylmethyl)(propyl)amino)pyrimidine-4-carboxamido)-3-methylbenzyl)(methyl)amino)acetate which was used directly without any further purification. The residue was taken up into DCM (4.5 ml) and TFA (0.5 ml) added. After stirring at RT for 2 hours the solvent was removed in vacuo. The residue was taken up into dilute HCl and precipitated by basification to pH 3-4. The solid was removed by filtration, washed with water and dried to give the title compound as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08399448B2 |
|---|
| Source dataset | uspto-grants-2013_03 |
|---|
| ORD ID | ord-1ceeeb09d7fd4ce9af968d7fffbb6cad |
|---|
| Source note | uspto-grants-2013_03 |
|---|